Beijing, 8 August 2026 – Chinese artificial intelligence developers and medical technology conglomerates are rapidly positioning AI-driven healthcare solutions as the country’s next high-margin global growth engine. Spurred by domestic breakthroughs in medical large language models, automated diagnostic systems, and surgical robotics, Chinese healthtech firms are expanding aggressively beyond domestic borders. By exporting cost-effective, scalable AI diagnostic tools to emerging markets across Southeast Asia, the Middle East, and Latin America, China is establishing a formidable footprint in the rapidly evolving global digital health landscape.
Unlock the Full Article
This article is exclusive to The Ledger Asia Subsribers / PAID members.
Already have an account? Log in here
